WILLIAM E. ROTE - Chief Research Officer at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Research Officer
Issuer Symbol
TVTX on Nasdaq
All Insider Reports
All Insider Reports

WILLIAM E. ROTE - trading volume in the past year for Travere Therapeutics, Inc.

Holdings reported by WILLIAM E. ROTE for Travere Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 109,087 $3,585,689 $32.87 03 Feb 2026 Direct
Performance-based restricted stock units 4,920 $0 $23.53 02 May 2025 Direct Common Stock
Employee stock option (right to buy) 53,570 31 Jan 2026 Direct Common Stock

Transactions reported by WILLIAM E. ROTE for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.